" class="no-js "lang="en-US"> Humanity Health Announces $6 Million Series A Funding Round - Medtech Alert
Friday, February 07, 2025

Humanity Health Announces $6 Million Series A Funding Round

Humanity Health, the premier career acceleration and talent sourcing platform for underrepresented leaders in healthcare and life sciences, has raised $6 million in a Series A funding led by Jumpstart Nova with follow-on participation from Deerfield Management, which provided the initial seed capital for the company’s launch.

“Humanity Health has recognized that access to skilled, diverse leadership talent is a critical driver of growth, health equity and innovation in the healthcare sector,” says Kathryne Cooper, a partner with Jumpstart Nova. “Their innovative and technology-enabled approach to addressing this need through executive recruitment, executive development and pipeline development is the most comprehensive we have seen in the market.”

Humanity Health will use the new funding to expand its base of C-Suite and executive level leaders who are members in the Humanity Talent Network (HTN), a private membership community of leaders who identify as women and/or people of color. Through HTN, each member is matched with their own executive career strategist and delivered opportunities such as board positions, executive roles and investor introductions that are personalized to their expertise and preferences. Members are also invited to join Collectives, curated small group forums of subject matter experts engaging around career advancement, thought leadership, mentorship and collaboration. HTN is powered by native mobile applications developed by the company.

“We are extremely excited to have Jumpstart Nova join the Humanity Health family. It is exciting to have investors that both intimately understand the healthcare market and have a proven commitment to DEI as investors,” says Ron Mitchell, co-founder and CEO of Humanity Health. “Combined with Deerfield Management, we now have two of the most deeply connected and successful investors in healthcare to support our growth with capital, expertise and access.”

The fundraise will also allow Humanity Health to help companies across the healthcare and life sciences industries connect with highly qualified and talented women and people of color for leadership positions.

“From the outset, we were excited by the mission of Humanity Health,” says Heather Wasielewski-Lopez, Chief People Officer at Evergreen Nephrology. “Our organization has a true commitment to diversity, equity and inclusion. We were looking for a partner with a similar ethos that could execute at the scale and speed we needed. We found that in Humanity Health.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more